Winnipeg Free Press - PRINT EDITION
Posted: 06/27/2013 1:00 AM | Comments: 0
A two year-old Winnipeg medical device company that's developing a hand-held gamma camera that can be used to increase the success in breast cancer surgery has landed a $500,000 investment from a group of local investors.
Cubresa Inc. is developing the world's only hand-held gamma camera, which is smaller than fixed gamma cameras and larger than tiny probe devices that are in use now.
James Schellenberg, founder and CEO of the company, said a reasonable expectation is for the company to have product in the market by the fall of 2014. He said it's not determined yet whether regulatory approval will be sought first in Canada, the U.S or Germany.
Even though the devices do not yet have approval, Cubresa has already started to earn revenue by selling elements of its technology to original equipment manufacturers who can integrate it into their current quality-controlled products.
"So we do have things for sale today that we don't need regulatory approval for," Schellenberg said. "With this new investment from Manitoba Knights we'll be able to do more design work on the camera, develop our customer base and do a little more marketing."
Cubresa is part of the Manitoba Technology Accelerator program (formerly Biomedical Commercialization Canada).
Marshall Ring, executive director of the Manitoba Technology Accelerator (MTA) program co-founded the angel investment group, called Manitoba Knights, in the fall of 2011 with local investor Harry Ethans and a group of investors representing about $10 million of investable capital.
They are not restricted to MTA companies but have a bird's-eye view on how those companies are developing and Cubresa has been on their radar screen for a while now.
Ethans said, "We have been watching Cubresa grow over the past 18 months. When it reached the criteria our group has for investment there was great enthusiasm from our group to get involved."
Ring said the Cubresa deal was a perfect fit for the Manitoba Knights.
"This is in the absolute sweet spot for what the Knights want to do," Ring said. "The Knights wanted the company to get to a certain level before they invested. We established where the investment line is and we have been working with the company to get to that point and our investors have now seen them hit a milestone or two."
The milestones achieved include a defined product with detailed specifications rather than just a platform technology. As well Cubresa has what Ring refers to as an "X,Y,Z" letter.
"That's a letter from a potential customer saying "I will buy X number of units at Y price subject to product specifications Z'," he said.
In terms of the size and manner of use for the hand-held gamma camera, Schellenberg said it's like an ultrasound but it is looking for cancer tumours in lymph nodes.
"Right after the doctor takes out the tumour, the next thing you want to know is if the lymph nodes are malignant," said Schellenberg. "Our small hand-held camera is a good surgical tool for imaging those sentinel lymph nodes."
Largely self-funded to date, Schellenberg, like several of his current staff of six full-time and five part-time people, is a former senior staff member of IMRIS Inc. the intra-operative magnetic resonance imaging equipment manufacturer.
IMRIS, which was also founded in Winnipeg, is in the process of moving its entire operation to Minneapolis. Schellenberg said his company has been fortunate to hire some high-level staffers from that company who did not want to relocate.
Republished from the Winnipeg Free Press print edition June 27, 2013 B4
Have you found an error, or know of something we’ve missed in one of our stories? Please use the form below and let us know.
Having problems with the form?Contact Us Directly
NYC's Met opera still negotiating with 10 unions
Macy's to pay $650,000 in shopper-profiling probe
US safety agency offers online recall check
Free the booze, drink in the profits: study
Japan trade deficit widens, exports up slightly
Singer Ray J denies crimes at Beverly Hills hotel
Eatery that served toxic tea had labeling citation
Lucrative Grand Canyon contract up for bid again
Anna Nicole Smith's estate loses bid for millions
Funds earmarked for startups
PetSmart to consider selling itself
FDA approves new drug for rare genetic disease
Uber hires former Obama adviser Plouffe
US wants to make cars talk to each other
Attorney blasts fatal police shooting at Wal-Mart
Prison company pays $8 million in back wages
Peanut, almond butter recalled for salmonella risk
How the Dow Jones industrial average fared Tuesday
Uber hires former Obama adviser
Fork lift load falls on man, fatally injuring him
Most actively traded companies on the TSX
List of Penn West class action lawsuits grows
Audit: 'Obamacare' tax not meeting revenue target
The top 10 books on Apple's iBooks
Spotify's Top 10 most viral tracks
US stocks move higher; Home Depot rises
Committee approves higher pension calculations
Trudeau blasts Harper's pipeline policy
Grain mixed and livestock higher
WWII bomb found near Frankfurt airport
Defence grills plant manager in salmonella trial
AP Exclusive: US changing no-fly list rules
WhiteWave to remove ingredient from Horizon, Silk
NY regulators sanction Standard Chartered Bank
Ballmer steps down from Microsoft board
Islanders announce sale of minority stake of club
CEO of bankrupt oil company sentenced in scheme
Farmers given more time to repay cash advances
AstraZeneca says DOJ closes probe into drug trial